Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Assessment of effective absorbed dose of (111)In-DTPA-Buserelin in human on the basis of biodistribution rat data.

Lahooti A, Shanehsazzadeh S, Jalilian AR, Tavakoli MB.

Radiat Prot Dosimetry. 2013 Apr;154(1):1-8. doi: 10.1093/rpd/ncs137. Epub 2012 Aug 8.

PMID:
22874898
2.

Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats.

Shanehsazzadeh S, Jalilian AR, Sadeghi HR, Allahverdi M.

Radiat Prot Dosimetry. 2009 Jun;134(2):79-86. doi: 10.1093/rpd/ncp085.

PMID:
19470447
3.

Radiation dosimetry for indium-111-pentetreotide.

Stabin MG, Kooij PP, Bakker WH, Inoue T, Endo K, Coveney J, de Jong R, Minegishi A.

J Nucl Med. 1997 Dec;38(12):1919-22.

4.

Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.

Cremonesi M, Ferrari M, Chinol M, Stabin MG, Grana C, Prisco G, Robertson C, Tosi G, Paganelli G.

Eur J Nucl Med. 1999 Feb;26(2):110-20.

PMID:
9933344
5.

Determination of human absorbed dose of 201Tl(III)-DTPA-HIgG based on biodistribution data in rats.

Khorrami Moghaddam A, Reza Jalilian A, Hayati V, Shanehsazzadeh S.

Radiat Prot Dosimetry. 2010 Oct;141(3):269-74. doi: 10.1093/rpd/ncq172. Epub 2010 Jun 16.

PMID:
20554580
6.

A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.

Konijnenberg MW, Bijster M, Krenning EP, De Jong M.

J Nucl Med. 2004 Jul;45(7):1260-9. Erratum in: J Nucl Med. 2009 Dec;50(12):2092.

7.

Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.

Barone R, Walrand S, Konijnenberg M, Valkema R, Kvols LK, Krenning EP, Pauwels S, Jamar F.

Nucl Med Commun. 2008 Mar;29(3):283-90. doi: 10.1097/MNM.0b013e3282f3d03e.

PMID:
18349800
8.

Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results.

Kauppinen TA, Bergström KA, Heikman P, Hiltunen J, Ahonen AK.

Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):132-6. Epub 2002 Nov 9.

PMID:
12483421
9.

Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran .

Hoh CK, Wallace AM, Vera DR.

Nucl Med Biol. 2003 Jul;30(5):457-64.

PMID:
12831982
10.

Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine in humans on the basis of biodistribution data of rats.

Sadeghzadeh M, Shanehsazzadeh S, Lahooti A.

Nucl Med Commun. 2015 Jan;36(1):90-4. doi: 10.1097/MNM.0000000000000210.

PMID:
25230055
11.
12.

Radiation dosimetry estimates of [18F]-fluoroacetate based on biodistribution data of rats.

Zhang JP, Zhang YJ, Xu JY, Yang ZY.

Appl Radiat Isot. 2012 Jan;70(1):332-5. doi: 10.1016/j.apradiso.2011.09.025. Epub 2011 Oct 13.

PMID:
22019094
13.

Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.

Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA.

J Nucl Med. 2003 Aug;44(8):1315-21.

14.

Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.

Cona MM, Koole M, Feng Y, Liu Y, Verbruggen A, Oyen R, Ni Y.

Int J Oncol. 2014 Mar;44(3):819-29. doi: 10.3892/ijo.2013.2217. Epub 2013 Dec 17.

PMID:
24366374
16.

Assessment of human effective absorbed dose of 67 Ga-ECC based on biodistribution rat data.

Shanehsazzadeh S, Yousefnia H, Lahooti A, Zolghadri S, Jalilian AR, Afarideh H.

Ann Nucl Med. 2015 Feb;29(2):118-24. doi: 10.1007/s12149-014-0917-7. Epub 2014 Oct 14.

PMID:
25311500
17.

Radiation dose estimates in humans for (11)C-acetate whole-body PET.

Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, Phelps ME, Barrio JR.

J Nucl Med. 2004 Jul;45(7):1233-6.

18.

Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.

Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K.

J Nucl Med. 2003 Jun;44(6):947-52.

19.

Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.

Lahorte CM, van de Wiele C, Bacher K, van den Bossche B, Thierens H, van Belle S, Slegers G, Dierckx RA.

Nucl Med Commun. 2003 Aug;24(8):871-80.

PMID:
12869819
20.

1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.

Virta JR, Tolvanen T, Någren K, Brück A, Roivainen A, Rinne JO.

J Nucl Med. 2008 Mar;49(3):347-53. doi: 10.2967/jnumed.107.047233. Epub 2008 Feb 20.

Supplemental Content

Support Center